l-Arginine supplementation enhances eNOS expression in experimental model of hypercholesterolemic rabbits aorta

Pathophysiology

Volumn 16, Issue 1, 2009, Pages 9-13

  Javanmard, Shaghayegh Haghjooy ^a   Nematbakhsh, Mehdi ^a   Mahmoodi, Farzaneh ^a   Mohajeri, Mohamad Reza ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerosis; eNOS; iNOS; l Arginine; Nitric oxide

Indexed keywords

ARGININE; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BLOOD VESSEL WALL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG MECHANISM; EXPERIMENTAL MODEL; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; INTIMA; LIPOPROTEIN BLOOD LEVEL; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RABBIT; SHAM FEEDING;

EID: 64249140512     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2008.11.003     Document Type: Article

References (35)

1. Napoli C., de Nigris F., Williams-Ignarro S., Pignalosa O., Sica V., and Ignarro L.J. Nitric oxide and atherosclerosis: an update. Nitric Oxide 15 (2006) 265-279
2. Minor Jr. R.L., Myers P.R., Guerra Jr. R., Bates J.N., and Harrison D.G. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J. Clin. Invest. 86 (1990) 2109-2116
3. Collin B., Busseuil D., Zeller M., Perrin C., Barthez O., Duvillard L., Vergely C., Bardou M., Dumas M., Cottin Y., and Rochette L. Increased superoxide anion production is associated with early atherosclerosis and cardiovascular dysfunctions in a rabbit model. Mol. Cell. Biochem. 294 (2007) 225-235
4. Ignarro L.J., and Napoli C. Novel features of nitric oxide, endothelial nitric oxide synthase and atherosclerosis. Curr. Diab. Rep. 5 (2005) 17-23
5. Cayatte A.J., Palacino J.J., Horten K., and Cohen R.A. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler. Thromb. Vasc. Biol. 14 (1994) 746-752
6. Wink D.A., and Mitchell J.B. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free. Radic. Biol. Med. 25 (1998) 434-456
7. Huang P.L. Endothelial nitric oxide synthase and endothelial dysfunction. Curr. Hypertens. Rep. 5 (2003) 473-480
8. Braam B., and Verhaar M.C. Understanding eNOS for pharmacological modulation of endothelial function: a translational view. Curr. Pharm. 13 (2007) 1727-1740
9. Aktan F. iNOS-mediated nitric oxide production and its regulation. Life. Sci. 75 (2004) 639-653
10. Esaki T., Hayashi T., Muto E., Yamada K., Kuzuya M., and Iguchi A. Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits. Atherosclerosis 128 (1997) 39-46
11. Buttery L.D., Springall D.R., Chester A.H., Evans T.J., Standfield N., Parums D.V., Yacoub M.H., and Polak J.M. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab. Invest. 75 (1996) 77-85
12. Yan Z.Q., and Hansson G.K. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ. Res. 82 (1998) 21-29
13. Wilcox J.N., Subramanian R.R., Sundell C.L., Tracey W.R., Pollock J.S., Harrison D.G., and Marsden P.A. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 2479-2488
14. Shears L., Kawaharada N., Tzeng E., Billiar T.R., Watkins S.C., Kovesdi I., Lizonova A., and Pham S.M. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J. Clin. Invest. 100 (1997) 2035-2042
15. Kuhlencordt P.J., Chen J., and Huang P.L. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation 103 (2001) 3099-3104
16. Radi R., Beckman J.S., Bush K.M., and Freeman B.A. Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266 (1991) 4244-4250
17. Kuhlencordt P.J., Gyurko R., Han F., Scherrer-Crosbie M., Aretz T.H., Hajjar R., Picard M.H., and Huang P.L. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 104 (2001) 448-454
18. Knowles J.W., Reddick R.L., Jennette J.C., Shesely E.G., Smithies O., and Maeda N. Enhanced atherosclerosis and kidney dysfunction in eNOS (-/-) Apoe (-/-) mice are ameliorated by enalapril treatment. J. Clin. Invest 105 (2000) 451-458
19. Cooney R., Hynes S.O., Sharif F., Howard L., and O'Brien T. Effect of gene delivery of NOS isoforms on intimal hyperplasia and endothelial regeneration after balloon injury. Gene. Ther. 14 (2007) 396-404
20. Channon K.M., Qian H., Neplioueva V., Blazing M.A., Olmez E., Shetty G.A., Youngblood S.A., Pawloski J., McMahon T., Stamler J.S., and George S.E. In vivo gene transfer of nitric oxide synthase enhances vasomotor function in carotid arteries from normal and cholesterol-fed rabbits. Circulation 98 (1998) 1905-1911
21. Miller M.R., and Megson I.L. Recent developments in nitric oxide donor drugs. Br. J. Pharmacol. 151 (2007) 305-321
22. Morris Jr. S.M. Arginine: beyond protein. Am. J. Clin. Nutr. 83 (2006) 508S-512S
23. Kagemann G., Sies H., and Schnorr O. Limited availability of l-arginine increases DNA-binding activity of NF-kappaB and contributes to regulation of iNOS expression. J. Mol. Med. 85 (2007) 723-732
24. Tousoulis D., Boger R.H., Antoniades C., Siasos G., Stefanadi E., and Stefanadis C. Mechanisms of disease: l-arginine in coronary atherosclerosis-a clinical perspective. Nat. Clin. Pract. Cardiovasc. Med. 4 (2007) 274-283
25. Morris C.R., Poljakovic M., Lavrisha L., Machado L., Kuypers F.A., and Morris S.M. Decreased arginine bioavailability and increased serum arginase activity in asthma. Am. J. Respir. Crit. Care Med. 170 (2004) 148-153
26. Wittmann F., Prix N., Mayr S., Angele P., Wichmann M.W., van den Engel N.K., Hernandez-Richter T., Chaudry I.H., Jauch K.W., and Angele M.K. l-Arginine improves wound healing after trauma-hemorrhage by increasing collagen synthesis. J. Trauma 59 (2005) 162-168
27. Zhang J., Xia L., Zhang X., Yang W., and Bai M. Influence of l-arginine on the expression of eNOS and COX2 in experimental pulmonary thromboembolism. J. Huazhong Univ. Sci. Technol. Med. Sci. 26 (2006) 524-527
28. Cayatte A.J., Palacino J.J., Horten K., and Cohen R.A. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler. Thromb. 14 (1994) 753-759
29. Kauser K., da Cunha V., Fitch R., Mallari C., and Rubanyi G.M. Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Physiol. Heart. Circ. Physiol. 278 (2000) H1679-H1685
30. Knowles J.W., Reddick R.L., Jennette J.C., Shesely E.G., Smithies O., and Maeda N. Enhanced atherosclerosis and kidney dysfunction in eNOS (-/-) Apoe (-/-) mice are ameliorated by enalapril treatment. J. Clin. Invest. 105 (2000) 451-458
31. Hayashi T., Sumi D., Juliet P.A., Matsui-Hirai H., Asai-Tanaka Y., Kano H., Fukatsu A., Tsunekawa T., Miyazaki A., Iguchi A., and Ignarro L.J. Gene transfer of endothelial NO synthase, but not eNOS plus inducible NOS, regressed atherosclerosis in rabbits. Cardiovasc. Res. 61 (2004) 339-351
32. Mujynya-Ludunge K., Viswambharan H., Driscoll R., Ming X.F., von Segesser L.K., Kappenberger L., Yang Z., and Vassalli G. Endothelial nitric oxide synthase gene transfer restores endothelium-dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E-deficient mice. Basic Res. Cardiol. 100 (2005) 102-111
33. Zanetti M., d'Uscio L.V., Kovesdi I., Katusic Z.S., and O'Brien T. In vivo gene transfer of inducible nitric oxide synthase to carotid arteries from hypercholesterolemic rabbits. Stroke 34 (2003) 1293-1298
34. Detmers P.A., Hernandez M., Mudgett J., Hassing H., Burton C., Mundt S., Chun S., Fletcher D., Card D.J., Lisnock J., Weikel R., Bergstrom J.D., Shevell D.E., Hermanowski-Vosatka A., Sparrow C.P., Chao Y.S., Rader D.J., Wright S.D., and Puré E. Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J. Immunol. 165 (2000) 3430-3435
35. Hayashi T., Matsui-Hirai H., Fukatsu A., Sumi D., Kano-Hayashi H., Rani P.J.A., and Iguchi A. Selective iNOS inhibitor, ONO1714 successfully retards the development of high-cholesterol diet induced atherosclerosis by novel mechanism. Atherosclerosis 187 (2006) 316-324